A voluntary, nationwide recall has been issued for a common ADHD medication, lisdexamfetamine dimesylate
The U.S. Food and Drug Administration has designated this a Class II recall, meaning it is unlikely to cause serious, long-term harm
Affected patients should not stop taking their medication suddenly but should contact their doctor or pharmacy immediately
MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.Â
Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHD treatment prescribed for people over age 6.
The U.S. Food and Drug Administration (FDA) classified the recall as a Class II risk. This indicates that using the product "may cause temporary or medically reversible adverse health consequences," but the probability of serious harm is considered remote.
The reason for the recall is a failure in laboratory testing. The FDA said the affected lots of medication did not dissolve as expected during tests.
This problem could affect how well the drug works in the body, potentially resulting in patients not getting the intended dose and the full therapeutic benefit.
Lisdexamfetamine dimesylate is a widely used drug, with data showing that over nine million prescriptions were dispensed in 2023, according to Newsweek.
The recall covers 100-count bottles across a range of doses.
The affected lot numbers and expiration dates are:
10 mg: AD42468 (exp. 2/28/2026), AD48705 (exp. 4/30/2026)
20 mg: AD42469 (exp. 2/28/2026), AD48707 (exp. 4/30/2026)
30 mg: AD42470 (exp. 2/28/2026), AD48708 (exp. 4/30/2026)
40 mg: AD48709 (exp. 4/30/2026), AD50894 (exp. 5/31/2026)
50 mg: AD48710 (exp. 4/30/2026), AD50895 (exp. 5/31/2026)
60 mg: AD48711 (exp. 4/30/2026), AD50896 (exp. 5/31/2026)
70 mg: AD48712 (exp. 4/30/2026), AD50898 (exp. 5/31/2026)
The FDA recommends patients contact their health care provider before stopping any medication abruptly and seek additional guidance.
More information
For a full list of recalled products and additional details, visit the U.S. Food and Drug Administration’s enforcement reports page.
SOURCES: Newsweek, Nov. 6, 2025; U.S. Food and Drug Administration, enforcement report, Oct. 28, 2025
If your bottle of lisdexamfetamine dimesylate capsules is part of the recall, contact your prescribing physician or pharmacy immediately for instructions on getting a safe replacement.
Originally published on healthday.com, part of the BLOX Digital Content Exchange.
Information from the News and our advertisers (Want to add your business to this to this feed?)
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Sign up to receive notifications when a new Columbia Gorge News e-Edition is published.
Would you like to receive our news updates? Signup today!
Receive weekly updates on obituaries and death notices.
Oregon Capital Press presented by Columbia Gorge News
Receive updates on upcoming promotions and special sections.
Receive weekly updates on local sports news.
Sorry, an error occurred.
Already Subscribed!
Cancel anytime
Thank you .
Your account has been registered, and you are now logged in.
Check your email for details.
Submitting this form below will send a message to your email with a link to change your password.
An email message containing instructions on how to reset your password has been sent to the email address listed on your account.
No promotional rates found.
Secure & Encrypted
Thank you.
Your gift purchase was successful! Your purchase was successful, and you are now logged in.
| Rate: | |
| Begins: | |
| Transaction ID: |
A receipt was sent to your email.
Commented
Sorry, there are no recent results for popular commented articles.